Reaction to study claiming to increase life expectancy in mice through gene therapy
A study published by the company Rejuvenate Bio claims to have prolonged the life expectancy of healthy older mice, while improving other health parameters. The study used a gene therapy—introducing three genes, known as Yamanaka factors, that are particularly active in embryonic cells. According to the authors, the remaining life expectancy of the mice (whose age was equivalent to about 77 years in humans) was doubled, with a 7% increase in absolute terms. The results have been shared in a pre-print publication and have not yet been peer-reviewed.